Liu et al. confirmed that ALKBH5 promotes the characteristics of cancer stem cells in TNBC and enhances its resistance to doxorubicin by regulating the m6A methylation modification of FOXO1 mRNA [31]. This evidence concerns the gene ALKBH5 and cancer.